GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $44,000 | -24.1% | 1,005 | -23.3% | 0.01% | -22.2% |
| Q4 2021 | $58,000 | +13.7% | 1,311 | -1.9% | 0.01% | -30.8% |
| Q3 2021 | $51,000 | +2.0% | 1,337 | +6.4% | 0.01% | +18.2% |
| Q2 2021 | $50,000 | +85.2% | 1,256 | +67.9% | 0.01% | +83.3% |
| Q1 2021 | $27,000 | -44.9% | 748 | -43.7% | 0.01% | -50.0% |
| Q4 2020 | $49,000 | +14.0% | 1,329 | +16.5% | 0.01% | 0.0% |
| Q3 2020 | $43,000 | -42.7% | 1,141 | -38.0% | 0.01% | -45.5% |
| Q2 2020 | $75,000 | -22.7% | 1,841 | -28.2% | 0.02% | -40.5% |
| Q1 2020 | $97,000 | -57.1% | 2,565 | -46.8% | 0.04% | -53.2% |
| Q4 2019 | $226,000 | +7.1% | 4,820 | -2.4% | 0.08% | -1.2% |
| Q3 2019 | $211,000 | +26.3% | 4,940 | +18.4% | 0.08% | +25.0% |
| Q2 2019 | $167,000 | +0.6% | 4,174 | +4.9% | 0.06% | -3.0% |
| Q1 2019 | $166,000 | +48.2% | 3,978 | +34.8% | 0.07% | +20.0% |
| Q4 2018 | $112,000 | – | 2,950 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |